Browsing by Subject Sulforaphane

Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)Rank
3-Jun-2024ANTI-FERROPTOTIC ACTION OF SULFORAPHANE IN SKELETAL MUSCLE OF DIABETIC MICEStančić, Ana; Markelić, Milica ; Savić, Nevena; Veličković, Ksenija ; Gudelj, Anđelija; Martinović, Vesna; Grigorov, Ilijana; Otašević, VesnaM34
Apr-2023Conducting bioinformatics analysis to predict sulforaphane-triggered adverse outcome pathways in healthy human cellsBozic, Dragica; Živančević, Katarina ; Baralić, Katarina; Miljaković, Evica Antonijević; Djordjević, Aleksandra Buha; Ćurčić, Marijana; Bulat, Zorica; Antonijević, Biljana; Đukić-Ćosić, DanijelaM21a
25-Dec-2021Predicting sulforaphane-induced adverse effects in colon cancer patients via in silico investigationBozic, Dragica; Baralić, Katarina; Živančević, Katarina S. ; Antonijević Miljaković, Evica; Ćurčić, Marijana; Antonijević, Biljana; Buha Djordjević, Aleksandra; Bulat, Zorica; Zhang, Yi; Yang, Li; Đukić-Ćosić, DanijelaM21
3-Jun-2024PROTECTIVE EFFECTS OF SULFORAPHANE AGAINST INJURY OF ENDOCRINE PANCREAS IN DIABETIC MICE INCLUDE ANTIFERROPTOTIC ACTIONMarkelić, Milica ; Stančić, Ana; Savić, Nevena; Veličković, Ksenija ; Martinović, Vesna; Gudelj, Anđelija; Grigorov, IlijanaM34
3-Jun-2024SULFORAPHANE ATTENUATES HMGB1-MEDIATED ACTIVATION OF INFLAMMATORY PATHWAYS IN THE LIVER OF DIABETIC MICE AND SUPPRESSES FERROPTOSISOtašević, Vesna; Stančić, Ana; Gudelj, Anđelija; Savić, Nevena; Markelić, Milica ; Veličković, Ksenija ; Martinović, Vesna; Grigorov, IlijanaM34
23-Apr-2023Sulforaphane prevents diabetes-induced liver ferroptosis through activation of Nrf2 signaling axisVesna Otašević; Ilijana Grigorov; Nevena Savić; Markelić, Milica ; Veličković, Ksenija ; Anđelija Gudelj; Vesna Martinović; Ana StančićM34